TAP2 and neoplasm: It has been shown that HDACi treatment can activate the proteasomal components (LMP2, LMP7), transporters associated with antigen processing (TAP1, TAP2) and the TAP-associated glycoprotein (tapasin) gene in tumor cells [91].